VNRX
VolitionRx Limited
NYSE American · usd
VolitionRx Limited (VNRX) trades at $0.1792 (+2.90%) as of 2:24:12 PM EDT on Oct 26, 2026, -30.83% over the past month. Market cap is $5.23M, with 1.0 days to cover in short interest.
Stock performance
How VolitionRx Limited (VNRX) stock has performed from one day to one year, with its 52-week range.
- 1D
- +2.90%
- 1W
- +3.08%
- 1M
- -30.83%
- YTD
- -96.50%
- 1Y
- -97.95%
- 52-wk range
- $0.16 – $9.50
Key statistics
Today's trading snapshot for VNRX: day range, open, previous close, volume and market cap.
- Day range
- $0.17 – $0.18
- Open
- $0.18
- Prev close
- $0.17
- Volume
- 439.36K
- Market cap
- $5.23M
- Shares out
- 18.73M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for VolitionRx Limited: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 2.08
- P/B
- -0.16
- P/FCF
- —
- ROE
- 81.1%
- ROA
- -314.4%
- Debt/Equity
- -0.34
- Div yield
- 0.00%
As of Oct 23, 2026
8-K filings
Material corporate events VolitionRx Limited has disclosed to the SEC on Form 8-K.
- Warrant or conversionSep 25, 2026
On September 18, 2026 the Company issued to Lind an aggregate of 698,113 shares of common stock to satisfy a $185,000 conversion obligation, and (b) on September 23, 2026 the Company issued to Lind an aggregate of 1,459,227 shares of common stock to satisfy a $340,000 conversion obligation.
- Warrant or conversionSep 15, 2026
“on September 2, 2026 the Company issued to Lind an aggregate of 706,214 shares of common stock to satisfy a $250,000 conversion obligation, and (b) on September 10, 2026 the Company issued to Lind an aggregate of 707,236 shares of common stock to satisfy a $215,000 conversion obligation.”
- Debt retirementSep 14, 2026
Pursuant to Section 1.4.1 of the 2025 Note, on September 11, 2026, the Company prepaid in cash the outstanding principal amount of the 2025 Note in the aggregate amount of approximately $422,000 (the "Prepayment"). Following the Prepayment, no further amounts remain outstanding under the 2025 Note.
- Warrant or conversionSep 2, 2026
On August 27, 2026 the Company issued to Lind an aggregate of 712,328 shares of common stock to satisfy a $260,000 conversion obligation, and ... issued ... 520,547 shares of common stock to satisfy a $190,000 conversion obligation ... [and] on August 31, 2026 ... issued ... shares of common stock to satisfy [five additional] conversion obligation[s].
- Covenant violationSep 2, 2026
On September 2, 2026, the Company and Lind entered into a waiver and consent (the "Waiver") pursuant to which Lind consented to any and all sales under the ATM Agreement, including amounts in excess of $10 million during any calendar year, as constituting Permitted ATM Sales and not Prohibited Transactions. The Waiver also waives ... any existing or future Events of Default ... arising from past or future sales under the ATM Agreement.
Dividend history and stock splits
VolitionRx Limited's recent dividend payments and stock splits.
Dividends
No recent dividends.
Splits
- 1-for-20Apr 28, 2026
VNRX short interest
How heavily VNRX is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 1.0
- Short interest
- 1.2M
- Avg volume
- 4.43M
As of · reported to FINRA twice monthly.
VNRX news
The latest news and headlines about VolitionRx Limited (VNRX).
- VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable MarketspositiveBenzinga· May 27, 2026
- Why Trinity Place Holdings Shares Are Trading Higher By 80%; Here Are 20 Stocks Moving PremarketBenzinga· Jan 3, 2024
- IO Biotech And 2 Other Stocks Under $2 Insiders Are BuyingBenzinga· Nov 27, 2023
- Ondas Holdings And 2 Other Stocks Under $1 Insiders Are BuyingBenzinga· Nov 20, 2023
- Top 4 Health Care Stocks That Are Preparing To Pump This QuarterBenzinga· Oct 6, 2023
Frequently asked questions
What is the VolitionRx Limited (VNRX) stock price today?
VolitionRx Limited (VNRX) is trading at $0.1792 (+2.90% on the day) as of 2:24:12 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is VolitionRx Limited?
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases…
What is the short interest in VNRX?
As of Sep 30, 2026, VNRX has 1.2M shares short and 1.0 days to cover.
What exchange is VNRX listed on?
VolitionRx Limited (VNRX) trades on NYSE American in USD, in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES industry.
Build with AI
Build an analysis of VNRX with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a VNRX analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.